CANCER VACCINE AND METHOD OF USE THEREOF Read more about CANCER VACCINE AND METHOD OF USE THEREOF US Application 63/162,990Filed on 2021-03-18
COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF GLYPICAN-3 (GPC3)-EXPRESSING TUMORS Read more about COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF GLYPICAN-3 (GPC3)-EXPRESSING TUMORS US Application 63/196,556Filed on 2021-06-03
SMALL MOLECULES TARGETING A NONCANONICAL, HAIRPIN-CONTAINING G-QUADRUPLEX STRUCTURE IN MYCN GENE Read more about SMALL MOLECULES TARGETING A NONCANONICAL, HAIRPIN-CONTAINING G-QUADRUPLEX STRUCTURE IN MYCN GENE US Application 63/208,918Filed on 2021-06-09
FLUOROGENIC HEPTAMETHINE NORCYANINES Read more about FLUOROGENIC HEPTAMETHINE NORCYANINES US Application 63/165,511Filed on 2021-03-24
Use Of Lentivector - Transduced T-RAPA Cells For Amelioration Of Lysosomal Storage Disorders Read more about Use Of Lentivector - Transduced T-RAPA Cells For Amelioration Of Lysosomal Storage Disorders US Application 62/663,786Filed on 2018-04-27
T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Read more about T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 US Application 63/185,805Filed on 2021-05-07
LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE Read more about LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE US Application 63/181,519Filed on 2021-04-29
Recurrence Gene Signature Across Multiple Cancer Types Read more about Recurrence Gene Signature Across Multiple Cancer Types US Application 62/728,339Filed on 2018-09-07
LABELING BIOLOGICAL PARTICLES USING ACOUSTOPHORESIS Read more about LABELING BIOLOGICAL PARTICLES USING ACOUSTOPHORESIS US Application 63/191,103Filed on 2021-05-20
USE OF STING AGONISTS TO AUGMENT CAR T CELL FUNCTION IN SOLID TUMORS Read more about USE OF STING AGONISTS TO AUGMENT CAR T CELL FUNCTION IN SOLID TUMORS US Application 62/932,913Filed on 2019-11-08